Drug Shortage Report for FLUNARIZINE
| Report ID | 133192 |
| Drug Identification Number | 02246082 |
| Brand name | FLUNARIZINE |
| Common or Proper name | Flunarizine |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUNARIZINE |
| Strength(s) | 5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 6 x 10 Blister |
| ATC code | N07CA |
| ATC description | ANTIVERTIGO PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-01-22 |
| Estimated end date | 2021-05-01 |
| Actual end date | 2021-04-20 |
| Shortage status | Resolved |
| Updated date | 2021-04-21 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.